It is a trading private limited company based in Shriharipark, Maharashtra, India, established in 2016.
2016 | Shriharipark, Maharashtra, India | ActiveRelevium Pharma Private Limited, a active private limited company, was established on 23 June 2016 in Shriharipark, Maharashtra, India. Engaging in other wholesale within the trading sector, it holds CIN: U74999MH2016PTC282810. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Shankar Bhagwanrao Jadhav (Director), Dnyaneshwar Gambhir Patil (Director). Past directors included Jeevan Bapurao Deshmukh, Urmila Shankar Jadhav, Anant Shyamrao Bhagwat. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No 4 Cts No15848/123 Madhav Nagar Shanoorwadi, Shriharipark, Maharashtra, 431001.
U74999MH2016PTC282810
282810
23 June 2016
₹0.50 M
₹0.50 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Relevium Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shankar Bhagwanrao Jadhav | Director | 15 Mar 2024 | Current |
| Dnyaneshwar Gambhir Patil | Director | 23 Jun 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 Mar 2024 | Past |
| Pramod Abcsdd | Director | 15 Mar 2024 | Past |
| Pramod Abcsdd | Director | 29 May 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Relevium Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 40.81% increase. The company also saw a substantial improvement in profitability, with a 133.26% increase in profit. The company's net worth Soared by an impressive increase of 14.71%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Relevium Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Relevium Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Relevium Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Relevium Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Relevium Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Relevium Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Progress on Shankar Bhagwanrao Jadhav was appointed as a Director was appointed as a Director on 15 Mar 2024 & has been associated with this company since 1 year 9 months . was documented.
Dnyaneshwar Gambhir Patil was appointed as a Director was appointed as a Director on 23 Jun 2016 & has been associated with this company since 9 years 6 months . was recorded as a recent event.
Progress on Relevium Pharma Private Limited was registered on 23 Jun 2016 with Roc Mumbai & aged 9 years 6 months as per MCA records. was documented.
The CIN of Relevium Pharma Private Limited is U74999MH2016PTC282810.
Relevium Pharma Private Limited is headquartered at Plot No 4 Cts No15848/123 Madhav Nagar Shanoorwadi, Shriharipark, Maharashtra, 431001.
Relevium Pharma Private Limited was incorporated on 23 June 2016.
The current directors of Relevium Pharma Private Limited are
The primary industry of Relevium Pharma Private Limited is Trading.
Relevium Pharma Private Limited is unlisted.
The authorized capital of Relevium Pharma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Relevium Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX